NCT02104765View on ClinicalTrials.gov

A Study of LY2951742 in Healthy Japanese and Caucasian Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Migraine Disorders
Interventions
DRUG

LY2951742

Administered subcutaneously.

DRUG

Placebo

Administered subcutaneously.

Trial Locations (1)

90630

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cypress

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02104765 - A Study of LY2951742 in Healthy Japanese and Caucasian Participants | Biotech Hunter | Biotech Hunter